A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
01/2003
01/02/2003	EP1267934A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
12/2002
12/31/2002	US6500630 Measuring level of pregnancy- associated plasma protein-a (papp-a) in biological sample from a non-pregnant patient; comparing level with that of control subjects; diagnosing inflammatory condition based on level of papp-acontrol
12/31/2002	US6500108 Stent, balloon catheter, wire, ribbon, or the like, covered with a gold layer having a radiation emitting self-assembled monolayer chemisorbed thereon
12/31/2002	CA2044812C Radiopharmaceutical formulations, their method of administration and process of preparation
12/27/2002	WO2002067767A3 Methods and systems which use annexin for bioprofiling body lumen
12/27/2002	WO2002020610A3 Conformationally constrained labeled peptides for imaging and therapy
12/27/2002	WO2002012467A3 Drug metabolizing enzymes
12/26/2002	US20020197681 Identification and uses of a hyaluronan receptor for endocytosis
12/26/2002	US20020197261 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
12/26/2002	US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/26/2002	US20020197210 Stabilized therapeutic and imaging agents
12/26/2002	US20020197208 Low density radionuclide-containing particulate material
12/26/2002	US20020197207 Radionuclide-coated particulate material
12/24/2002	US6498181 Enhancing humoral immune response in combination with cancer therapy including surgery, radiation and immunotherapy
12/24/2002	CA2065462C Radiopharmaceutical bacteriostats
12/20/2002	CA2413254A1 Preparations for measruing gastric ph value and method of measuring gastric ph value by using the same
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100863A1 Corticotropin releasing factor antagonists
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100479A2 Radioactive medical devices and methods of making radioactive medical devices
12/19/2002	WO2002100442A2 Use of l-polynucleotides and derivatives thereof for in vivo imaging
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100334A2 Use of radiopharmaceutical complexes in achieving transplantation tolerance
12/19/2002	WO2002080754A3 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002	WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002	WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002	WO2001068679A9 Peptides targeting specifically tumor-derived endothelial cells
12/19/2002	US20020193416 Synergistic tumorcidal response induced by histamine
12/19/2002	US20020193374 Administering to subject having cytomegalo viurs (CMV), an image-generating benzamide compound for diagnosing CMV
12/19/2002	US20020192223 Novel antibody conjugates reactive with human carcinomas
12/19/2002	US20020192214 Eosinophil eotaxin receptor
12/19/2002	US20020192162 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002	US20020192158 Detectably labeled porphyrin compound for identifying the sentinel lymph node
12/19/2002	US20020192157 Treatment and diagnosis of macrophage mediated disease
12/19/2002	CA2450262A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	CA2449941A1 Use of radiopharmaceutical complexes in achieving transplantation tolerance
12/19/2002	CA2449517A1 Tissue-specific endothelial membrane proteins
12/18/2002	EP1266884A1 Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265641A2 Imaging agents for diagnosis of parkinson's disease
12/18/2002	EP1079833A4 Cocaine receptor binding ligands
12/18/2002	EP0646019B9 Biotin-DOTA conjugates and their use in pretargeting methods
12/17/2002	US6495662 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
12/17/2002	CA2255573C Technetium-99m generator system
12/17/2002	CA2085464C Using 5,10,15,10-tetrakis (r-carboxyphenyl)porphine for detecting and treating lung cancer
12/17/2002	CA1341411C Method for producing fv fragments in eukaryotic cells
12/12/2002	WO2002099422A2 Individualization of therapy with alzheimer's disease agents
12/12/2002	WO2002098897A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002	WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002	WO2002098447A1 Cytotoxic or radioactive conjugates able to bind to oxytocin receptors
12/12/2002	WO2002098417A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
12/12/2002	WO2002082044A3 Method of imaging cell death in vivo
12/12/2002	WO2002058531A3 Ingestible device
12/12/2002	US20020188003 Cocaine receptor binding ligands
12/12/2002	US20020187975 Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids
12/12/2002	US20020187955 Method of inducing angiogenesis in nonischemic skeletal muscle
12/12/2002	US20020187744 Ventilating device for ventilating through a ridge
12/12/2002	US20020187153 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
12/12/2002	US20020187141 Composites that bind a multidrug transporter protein and an antigen associated with a tumor or infectious agent; determination whether the failure of traditional chemotherapy is due to multidrug resistant tumor cells
12/12/2002	US20020187100 Preferably the antibody is monoclonal antibody 81C6 or an antibody that binds to the epitope bound by monoclonal antibody 81C6.
12/12/2002	US20020187099 Stabilizing radionuclide-containing compositions against degradation caused by free radicals generated from the radionuclide by adding iodide ions
12/12/2002	CA2449316A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
12/12/2002	CA2447695A1 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002	CA2436408A1 Modified psma ligands and uses related thereto
12/11/2002	EP1264828A1 New inhibitor of urokinase
12/11/2002	EP1264603A1 Use of L-polynucleotides for in vivo imaging
12/11/2002	EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2002	EP1263776A2 Peptides targeting specifically tumor-derived endothelial cells
12/11/2002	EP1263741A1 Bifunctional chelating agent
12/11/2002	EP1263478A2 Functional radiographic imaging methods and agents
12/11/2002	EP1263477A1 Simultaneous multimodal measurement of physiological function
12/11/2002	EP1263463A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cells
12/11/2002	EP1263447A1 Optically-active nanoparticles for use in therapeutic and diagnostic methods
12/11/2002	EP0942741B1 Lectin compositions and uses thereof
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6491893 Compounds for targeting and imaging infection and inflammation
12/10/2002	US6491619 Radiation delivery catheters and dosimetry methods
12/10/2002	US6491617 Medical devices that resist restenosis
12/10/2002	CA2292621C Process and apparatus for production of bi-213 cations
12/10/2002	CA2093431C Ionically cross-linked polymeric microcapsules
12/05/2002	WO2002097116A2 Delivery system for nucleic acids
12/05/2002	WO2002096948A2 Engineered tetravalent antibodies and methods of use
12/05/2002	WO2002096417A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
12/05/2002	WO2002096367A2 Targeted multivalent macromolecules
12/05/2002	WO2002070018A3 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
12/05/2002	WO2002062397A3 Chelates of metals which can be activated by neutrons and their use for the measurement of labeled specimens
12/05/2002	US20020182169 Polymer precursors of radiolabeled compounds, and methods of making and using the same
12/05/2002	US20020182148 Medical diagnosis; scanning tissue, organs; albumin label with radioactive materials
12/05/2002	US20020182147 Vitronectin receptor antagonist pharmaceuticals
12/05/2002	CA2448570A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
12/04/2002	EP1262490A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF
12/04/2002	EP1261381A2 Use of radiopharmaceuticals and intraoperative radiation probe
12/04/2002	EP1261376A1 Antibodies against ctla4(cd152), conjugates comprising same, and uses thereof
12/04/2002	EP1261371A1 Membrane estrogen receptor-directed therapy in breast cancer
12/04/2002	EP1102601A4 Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells
12/04/2002	EP0784634B1 Modified radioantibody fragments for reduced renal uptake
12/04/2002	EP0703791B1 An iodinated neuroprobe for mapping monoamine reuptake sites
12/03/2002	US6489302 Of varous drugs (such as anticancer agents) that make use of glucose transporter to deliver drugs to site of action (such as across blood-brain barrier) more efficiently, thereby reducing side effects
12/03/2002	US6488909 Chelating agents as well as their tricarbonyl complexes with technetium and rhenium
12/03/2002	CA2259343C Novel radiopharmaceutical compositions and matrices and uses thereof

1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 243